Medindia LOGIN REGISTER
Medindia
Advertisement

Novel Biomarkers, Therapeutic Targets for Prevention and Treatment of Cardiovascular Diseases

by Iswarya on December 27, 2018 at 2:51 PM
Novel Biomarkers, Therapeutic Targets for Prevention and Treatment of Cardiovascular Diseases

New study finds that metabolomic biomarkers can help clinicians to identify cardiovascular disease risk and take preventive steps before the disease can surface. The findings of the study are published in the journal Cardiovascular & Hematological Disorders-Drug Targets.

Cardiovascular diseases (CVDs) are proven to be the leading cause of deaths throughout the world. If statistics are reviewed, almost four out of five deaths are due to myocardial infarction or stroke.

Advertisement


Efforts to prevent CVD have little effect on the decrease in the number of CVD related deaths despite many medical advances.

Therefore, the search for new and even better therapies and treatments for the betterment of those who are suffering from CVD is still in progress.
Advertisement

The field of metabolomics has offered a good solution to these diseases. Metabolomic biomarkers help clinicians to identify the risk of CVD and take preventive measures before the diseases can surface. Early diagnosis of CVD is a good sign for a patient's recovery and also for their health. Therefore, there is a need to establish reliable, sensitive and non-invasive biomarkers which can serve as therapeutic targets for the prevention and treatment of CVD.

In this study, analytical techniques are discussed along with the workflow that is used in untargeted metabolomics. Case studies that highlight the use of untargeted metabolomics in CVD research are also identified. Five of the case studies show approaches to identify untargeted metabolomics and apply this information in clinical situations. The analysis was conducted for the prediction of cardiovascular disease risk, myocardial ischemia, transient ischemic attack, incident coronary heart disease, and myocardial infarction risk.

The use of the untargeted metabolomics for risk assessment is still relatively new, and there is still a need for future advancements in metabolomics technologies.

Source: Eurekalert
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Heart Disease News

Smart Watch Helps Detect Irregular Heart Rhythm
Atrial fibrillation (irregular heart rhythm) can be accurately diagnosed with Verily Study Watch, the FDA-approved wrist-worn gadget.
Red Flags in Red Cells  Decoding Their Threat on Heart Health!
According to health experts, an increased risk of heart attack, stroke, and blood clots is associated with higher hemoglobin levels.
Atherosclerosis in Young Adults Curbed by Early Risk Factor Management
Early cardiac evaluation reverses atherosclerosis caused by cardiac risk factors like high BP and high cholesterol in young adults.
Summer Wildfires and Winter Air Pollution Pose Varied Heart Health Risks
PM2.5 increases during winter inversions are associated with higher heart attack risk, stated study.
Genetic Testing Identifies High Cholesterol Risk, Preventing Heart Events
The study underscores the significance of broader genetic testing for familial hypercholesterolemia, a genetic disorder that causes high bad cholesterol levels.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Novel Biomarkers, Therapeutic Targets for Prevention and Treatment of Cardiovascular Diseases Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests